Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 7
85
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Immunological Investigations Thematic: Editors’ Introduction

&

References

  • Bartley JM, Cadar AN, Martin DE. 2021. Better, faster, stronger: mRNA vaccines show promise for influenza vaccination in older adults. Immunol Invest. 50(7):810–820. doi:10.1080/08820139.2021.1909617.
  • Butterfield R, Dhanani S. 2021. The development of human papillomavirus (HPV) vaccines and current barriers to implementation. Immunol Invest. 50(7):821–832. doi:10.1080/08820139.2021.1897612
  • Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, Gerges-Geagea A, Leone A, Jurjus A. 2015. Vaccines through centuries: major cornerstones of global health. Front Public Health. 26(3):269. doi:10.3389/fpubh.2015.00269
  • Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. 2021. Pharmaceutical aspects and clinical evaluation of COVID-19 vaccines. Immunol Invest. 50(7):743–779. doi:10.1080/08820139.2021.1904977
  • Luo W, Yin Q. 2021. B cell response to vaccination. Immunol Invest. 50(7):780–801. doi:10.1080/08820139.2021.1903033
  • Mahmoodpoor A, Sanaie S, Samadi P, Yousefi M, Nader ND. 2021 Jun. SARS-CoV-2: unique challenges of the virus and vaccines. Immunol Invest. 50(7):802–809. doi:10.1080/08820139.2021.1936009. PMID: 34109900.
  • Mendoza P, Lorenzi JCC, Gaebler C. 2021. COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research. Curr Opin HIV AIDS. 16(1):25–35. doi:10.1097/COH.0000000000000657.
  • Ostrov BE, Amsterdam D. 2021. Interplay of anti-viral vaccines with biologic agents and immunomodulators in individuals with autoimmune and autoinflammatory diseases. Immunol Invest. 50(7):833–856. doi:10.1080/08820139.2021.1900863
  • Reis-Dennis S, Applewhite M. 2021. The ethics of vaccine allocation. Immunol Invest. 50(7):857–867. doi:10.1080/08820139.2021.1924771

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.